Lisa Hoffmann-Haas

[Nature Cancer @NatureCancer]

Our @NatureCancer Senior Editor @LisaHaas0107 Lisa Hoffmann-Haas is attending the CIMT meeting in Mainz 🇩🇪. Reach out to her if you want to discuss your science and publishing in Nature Cancer or find her at the meet-the-editor table (Booth #33) at 3PM today.

#CIMT2024

[Lisa Hoffmann-Haas @LisaHaas0107]

📢Registration is still open for - Advances in Cancer Vaccines ‼️

Taking place virtually next Thursday November 30th!

Sign up via the link below and check out the fantastic list of speakers!
Looking forward 😊

For free and brought to you by @moderna_tx and @NatureCancer!

[Nature Conferences @NatureConf]

Don't miss your chance to hear from these experts the latest developments in antigen discovery, preclinical and clinical advances in cancer vaccine therapies. brought to you by @moderna_tx & @NatureCancer

Reserve your spot: https://t.co/RlDorNznk1

[Lisa Hoffmann-Haas @LisaHaas0107]

Blue skies over beautiful Madrid 🇪🇸 for a busy Saturday at #ESMO23 - very impressive meeting so far, reach out if you want to discuss all things related to @NatureCancer.

@myESMO

[Runcie C.W. Chidebe @runciecwc]

Join us at the Roundtable on Black in cancer research presented by @DrBlueMD & @kilanbishop & Drs. Onyinye & Folu & @runciecwc, chaired by Kathryn Mcginnis, Dr Paraskevi Mallini & @LisaHaas0107
🗓️ Thursday 28th Sep 2023
⏲️ 14.00 PM (Europe/London) https://t.co/HxfuRgnx0C

[Lisa Hoffmann-Haas @LisaHaas0107]

@Marcus_Ruscetti @NatureCancer Thank you Marcus - was a pleasure to work with you on this! Congrats on the great story, very happy to see it published in Nature Cancer 🙂

[Lisa Hoffmann-Haas @LisaHaas0107]

@LeilaAkkari1 @NatureCancer @rweichselbaum @JustinLathia Thank you Leila, congrats to you and the team - very happy too see the study published 😍

[Cancer Immunotherapy @C_IMT]

Why do cancers resist treatment? At the 20th CIMT Annual Meeting in May, Samra Turajlic @TurajlicLab will share insights into the immune invasion mechanisms of kidney and skin cancers. Register for the conference at https://t.co/k6GB9OpLK7 #Europe'sCancerImmunotherapyMeeting

[Saur Lab @SaurLab]

Lost overview of all recent single-cell studies in #pancreaticcancer?👀

Check out our new @NatureCancer review with @StefanieBa, @ChiaraFalcomata, @fabian_theis & Roland Rad: https://t.co/dV2dqmpSet

#scRNA-seq #spatial #TME

[Lisa Hoffmann-Haas @LisaHaas0107]

Florence is certainly an amazing city for a conference ❤️ ☀️ what a place to talk about DNA damage & Immune Response. Looking forward #EASImmuneResponses!

[Nature Cancer @NatureCancer]

Attending “Immune Responses & DNA Repair” in beautiful Florence 🇮🇹 this week? Don’t miss the chance to meet our Senior Editor @LisaHaas0107 to discuss your work and all things related to publishing at @NatureCancer.

#EASImmuneResponses
@EACRnews @AACR

[Nature Cancer @NatureCancer]

Happy International Women's Day #IWD2023 !
@NatureCancer supports #WomenInScience - please join us to celebrate some of the wonderful female scientists & clinicians who recently published their work with us – we hope you are inspired by them! 👩‍🔬

[Lisa Hoffmann-Haas @LisaHaas0107]

@ErezNeta @alexia_zz @NatureCancer Thank you Neta and congratulations 👏- nice to see the study in press 🙂

[Lisa Hoffmann-Haas @LisaHaas0107]

I loved ❤️working on this - thank you for the contributions! Very inspiring to read about the dedication and thrive of junior PIs, the challenges that come with setting up a lab and the individual and creative solutions they find! Don't miss it #newPI #2022InReview @NatureCancer

[Nature Cancer @NatureCancer]

💫Recruiting, securing funding, building a network – early career investigators face many challenges! In “The 2022 generation” hear the inspiring stories of 12 PIs who started their teams in the past year. #newPI #2022InReview

https://t.co/j79Ng1oJfQ
https://t.co/g9Vuaq1mQm

[Lisa Hoffmann-Haas @LisaHaas0107]

Our @NatureCancer FOCUS issue on #2022InReview 🎉 is LIVE. Starting the holiday season with this one is becoming one of my favourite traditions ✨

[Nature Cancer @NatureCancer]

💫 OUR FAVOURITE TIME OF THE YEAR HAS ARRIVED 💫

As 2022 comes to an end @NatureCancer is proud to present our Focus Issue #2022InReview!

DON'T MISS all of its exciting content right here 👇

https://t.co/dRVcbCFEFa

[Mazzone Lab @LabMazzone]

Proud to share our work showing how tumor acidity controls pancreatic cancer cell metabolism and tumor immune landscape. Tampering with tumor acidity elicits anti-tumor immune responses and overcomes resistance to immunotherapy in pancreatic cancer models.
https://t.co/eBk0s89ACr

[Lisa Hoffmann-Haas @LisaHaas0107]

Amazing to hear how far the field of cancer #immunotherapy has come at #SITC2022 #SITC22👏. And some really inspiring discussions on where we have yet to go! Totally worth the trip from Germany to represent @NatureCancer 🥰

[Nature Cancer @NatureCancer]

💫Attending #SITC22 #SITC2022 in Boston 🇺🇸 this week?

Please reach out to Lisa Hoffmann-Haas @LisaHaas0107 during or after the meeting to discuss your work and ask questions❓ about publishing in @NatureCancer!

[Lisa Hoffmann-Haas @LisaHaas0107]

Traveling to Boston 🇺🇸 tomorrow for #SITC2022! Reach out to me if you want to discuss science and publishing in @NatureCancer 🔬💻
Getting very excited for 3 days full of #Immunotherapy 🤩

[Lisa Hoffmann-Haas @LisaHaas0107]

🥰Excited for the upcoming 3 days filled with science on so many interesting aspects of #CancerResearch at #CRCLSymposium in Lyon 🇨🇵

[Nature Cancer @NatureCancer]

Our @NatureCancer Editor @LisaHaas0107 is attending the #CRCL Symposium in Lyon 🇫🇷.
Approach her to discuss your work 🧪💊and everything you want to know about publishing in @NatureCancer!

#CancerResearch #CRCLSymposium #Cancerconference

[Nature Cancer @NatureCancer]

📢📢Do you love cancer research and are looking for an #EditorialCareer in #sciencepublishing?
One week left to apply and join our growing Editorial Team @NatureCancer ‼️ Details below.

Please spread the word and RT!

[Lisa Hoffmann-Haas @LisaHaas0107]

Excited to host this webcast - join us ‼️today‼️and ask all the questions you ever had about organoids and tumor-on-a-chip! #3DmodelsCancer

[Nature Cancer @NatureCancer]

📢HAPPENING TODAY - 5 more hours left to sign up and hear about cancer #organoids and #tumors on a chip from @KarunaMDPhD and @GVNlab. Join us for the talks and a live Q&A.

Registration is FREE 👇
https://t.co/ydbxLILiSE